These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18594839)

  • 21. Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.
    South SA; Hutton M; Farrell C; Mhawech-Fauceglia P; Rodabaugh KJ
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):543-5. PubMed ID: 17666659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confirmed pathogenic effect of a splice site variation in the MLH1 gene causing Lynch syndrome.
    Ruiz JL; Alvarez-Cubero MJ; Rosado FF; Espín EM; Bernal CE
    Int J Colorectal Dis; 2014 Aug; 29(8):1019-20. PubMed ID: 24811117
    [No Abstract]   [Full Text] [Related]  

  • 23. The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.
    Medeiros F; Lindor NM; Couch FJ; Highsmith WE
    J Mol Diagn; 2012; 14(3):264-73. PubMed ID: 22426235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families.
    Borràs E; Pineda M; Blanco I; Jewett EM; Wang F; Teulé A; Caldés T; Urioste M; Martínez-Bouzas C; Brunet J; Balmaña J; Torres A; Ramón y Cajal T; Sanz J; Pérez-Cabornero L; Castellví-Bel S; Alonso A; Lanas A; González S; Moreno V; Gruber SB; Rosenberg NA; Mukherjee B; Lázaro C; Capellá G
    Cancer Res; 2010 Oct; 70(19):7379-91. PubMed ID: 20858721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
    Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
    Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model.
    Lynch HT; Lynch JF; Attard TA
    CMAJ; 2009 Sep; 181(5):273-80. PubMed ID: 19654196
    [No Abstract]   [Full Text] [Related]  

  • 28. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
    Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
    Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.
    Pérez-Carbonell L; Alenda C; Payá A; Castillejo A; Barberá VM; Guillén C; Rojas E; Acame N; Gutiérrez-Aviñó FJ; Castells A; Llor X; Andreu M; Soto JL; Jover R
    J Mol Diagn; 2010 Jul; 12(4):498-504. PubMed ID: 20489114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMLH1 and HMSH2 germline mutations in Greek families with hereditary non-polyposis colorectal cancer.
    Kataki A; Gomatos IP; Arapis K; Mparatsis S; Alepas P; Kaintatzis A; Nikolopoulou M; Leandros E; Konstadoulakis MM; Bramis J
    Clin Genet; 2006 Mar; 69(3):290-3. PubMed ID: 16542397
    [No Abstract]   [Full Text] [Related]  

  • 31. Identifying Lynch syndrome.
    de la Chapelle A; Palomaki G; Hampel H
    Int J Cancer; 2009 Sep; 125(6):1492-3. PubMed ID: 19536819
    [No Abstract]   [Full Text] [Related]  

  • 32. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.
    Papp J; Kovacs ME; Olah E
    World J Gastroenterol; 2007 May; 13(19):2727-32. PubMed ID: 17569143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.
    Tinat J; Baert-Desurmont S; Latouche JB; Vasseur S; Martin C; Bouvignies E; Frébourg T
    Fam Cancer; 2008; 7(4):339-40. PubMed ID: 18496770
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hereditary non-polyposis colorectal cancer associated with hereditary gastric cancer. A case report.].
    Castañeda-Argáiz R; González-Contreras QH; Medina-Franco H; Rodríguez-Zentner HA; Tapia-Cid de León H; Vergara-Fernández O
    Rev Gastroenterol Mex; 2009; 74(3):256-8. PubMed ID: 19858019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The analysis for mRNA mutation of MLH1, MSH2 genes and the gene diagnosis for hereditary nonpolyposis colorectal cancer].
    Wang CF; Zhou XY; Zhang TM; Sun MH; Xu Y; Shi DR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):32-6. PubMed ID: 16456782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer.
    Hitchins MP; Ward RL
    J Med Genet; 2009 Dec; 46(12):793-802. PubMed ID: 19564652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.